Cargando…

Key Fibrogenic Signaling

Fibrosis is defined as an excessive accumulation of extracellular matrix components that lead to the destruction of organ architecture and impairment of organ function. Moreover, fibrosis is an intricate process attributable to a variety of interlaced fibrogenic signals and intrinsic mechanisms of a...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Weichun, Dai, Chunsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419200/
https://www.ncbi.nlm.nih.gov/pubmed/25973345
http://dx.doi.org/10.1007/s40139-015-0077-z
_version_ 1782369541568856064
author He, Weichun
Dai, Chunsun
author_facet He, Weichun
Dai, Chunsun
author_sort He, Weichun
collection PubMed
description Fibrosis is defined as an excessive accumulation of extracellular matrix components that lead to the destruction of organ architecture and impairment of organ function. Moreover, fibrosis is an intricate process attributable to a variety of interlaced fibrogenic signals and intrinsic mechanisms of activation of myofibroblasts. Being the dominant matrix-producing cells in organ fibrosis, myofibroblasts may be differentiated from various types of precursor cells. Identification of the signal pathways that play a key role in the pathogenesis of fibrotic diseases may suggest potential therapeutic targets. Here, we emphasize several intracellular signaling pathways that control the activation of myofibroblasts and matrix production.
format Online
Article
Text
id pubmed-4419200
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-44192002015-05-11 Key Fibrogenic Signaling He, Weichun Dai, Chunsun Curr Pathobiol Rep Matrix Pathobiology (Youhua Liu, Section Editor) Fibrosis is defined as an excessive accumulation of extracellular matrix components that lead to the destruction of organ architecture and impairment of organ function. Moreover, fibrosis is an intricate process attributable to a variety of interlaced fibrogenic signals and intrinsic mechanisms of activation of myofibroblasts. Being the dominant matrix-producing cells in organ fibrosis, myofibroblasts may be differentiated from various types of precursor cells. Identification of the signal pathways that play a key role in the pathogenesis of fibrotic diseases may suggest potential therapeutic targets. Here, we emphasize several intracellular signaling pathways that control the activation of myofibroblasts and matrix production. Springer US 2015-04-05 2015 /pmc/articles/PMC4419200/ /pubmed/25973345 http://dx.doi.org/10.1007/s40139-015-0077-z Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Matrix Pathobiology (Youhua Liu, Section Editor)
He, Weichun
Dai, Chunsun
Key Fibrogenic Signaling
title Key Fibrogenic Signaling
title_full Key Fibrogenic Signaling
title_fullStr Key Fibrogenic Signaling
title_full_unstemmed Key Fibrogenic Signaling
title_short Key Fibrogenic Signaling
title_sort key fibrogenic signaling
topic Matrix Pathobiology (Youhua Liu, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419200/
https://www.ncbi.nlm.nih.gov/pubmed/25973345
http://dx.doi.org/10.1007/s40139-015-0077-z
work_keys_str_mv AT heweichun keyfibrogenicsignaling
AT daichunsun keyfibrogenicsignaling